BIOSYNTH

BIOSYNTH

Biosynth is a worldwide leader in high-quality in-vitro diagnostic reagents, offering an exceptional selection of research tools, specialized products for various research areas, and customized services designed for scientists and manufacturers in in-vitro diagnostics and research labs.

Biosynth has carefully assembled a comprehensive offering, including:
• Largest Provider of Bulk Disease State Plasma in Europe
• Custom Antigen Manufacturing (ISO 13485:2016)
• Routine Bulk Antigen and Antibody Production
• Full Chemiluminescence Raw Material Menu
• Extensive Range for Emerging Diseases: A curated selection of first-to-market proteins and monoclonal antibodies for viruses like Monkeypox, Zika, Chikungunya, Dengue, and SARS-CoV-2.
• Support for Key Research Areas: A vast array of products for cancer, infectious disease, tropical viruses, neuroscience, endocrinology, immunology, and veterinary science.

Custom Manufacturing, Microbiology, Research Products, Anti-Microbial Agents, Antibodies/Antibody Services, Biochemical Markers, Biochemicals, Biologicals, Buffers, Bulk Chemicals, Chemistry Diag/Reagents/Kits, Chromogenic Substrates, Diabetes Markers, Enzymes, Immunoassay Diag/Reagents/Kits, Mono/Polyclonal Antibodies, Nucleic Acids, Peptides, Reagents, Substrates, Product Development/Services, Service Support, Accreditation/Certification, Quality Assurance, Quality Control & Management